TrialBlood advances2026

Impact of EBV status and histology on patient outcomes with nivolumab-AVD vs BV-AVD in advanced classic Hodgkin lymphoma (S1826).

Sairah Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.